Knockdown of TRIM46 significantly decreased the nuclear translocation of β-catenin in ovarian cancer cells, suggesting that TRIM46 expression is positively associated with activation of the Wnt/β-catenin pathway (Figure 5B). Here, TRIM46 is linked to ovarian carcinoma.